Crunching the numbers for LGND... Refresh in a moment for the full analysis.
LIGAND PHARMACEUTICALS INC (LGND)
Healthcare
mixed
$204.92
Updated: 2026-04-12
56
TradeApes Score
hold
Financial Strength
60
Healthy
Operating Trend
55
Mixed
Valuation
50
Mixed
Capital Allocation
50
Mixed
Risk
70
Healthy
Key Findings
+
Net cash position — more cash on hand than total debt
−
Large FCF burn — cash consumption exceeds 10% of revenue
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.